Back to search

Netherlands· NL-3f4b327d2693

Danaparoid natrium Viatris, 750 anti-Xa-eenheden, oplossing voor injectie

A danaparoid product containing danaparoid natrium, registered in Netherlands by Viatris Limited. The same ATC class is registered in 9 of our 19 countries.

ATC B01AB09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDanaparoid natrium Viatris, 750 anti-…ATCB01AB09REGISTER NO.NL-3f4b327d2693PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Danaparoid is registered in 9 of 19 countries.

Countries holding a registration under ATC B01AB09 (danaparoid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

Danaparoid · ATC B01AB09

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DANAPAROID NATRIUM
Manufacturer
Viatris Limited
Country
Netherlands (NL)
ATC code
B01AB09
ATC class
Danaparoid
Defined daily dose
1.5 TSD, E
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    120957

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

145 interactions on record for danaparoid.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Danaparoid · interactions on record

145 records

  • 94 severe
  • 51 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af772c13-bcb0-4174-82b4-8a602fa406ad
GET /v1/drugs/af772c13-bcb0-4174-82b4-8a602fa406ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik, Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120957_smpc.pdf",
  "strength": null,
  "atc_label": "Danaparoid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120957",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMSULFIET 0-WATER (E 221)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "DANAPAROID NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120957.pdf",
  "authorised_at": "2020/11/24",
  "procedure_number": "NL/H/3998/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120957",
  "additional_monitoring": "N"
}

See everything about danaparoid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.